Abiopharma

🔍 DUNN JEFFREY W (Executive)

Company: SI-BONE, Inc. (SIBN)

Report Date: 2025-12-08

Detailed Transactions and Holdings:

• Acquired 1,241 shares of Common Stock at $4.32 per share (Direct)
  Date: 2025-12-08 | Code: M | equity_swap_involved: false | shares_owned_after: 11,548.00 | transaction_form_type: 4
• Sold 1,241 shares of Common Stock at $19.3297 per share (Direct)
  Date: 2025-12-08 | Code: S | equity_swap_involved: false | shares_owned_after: 10,307.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 18,759 shares of Common Stock at $19.3297 per share (Direct)
  Date: 2025-12-08 | Code: S | equity_swap_involved: false | shares_owned_after: 110,115.00 | transaction_form_type: 4 | Footnotes: F1, F2, F4
• Sold 1,241 shares of Stock Option (Right to Buy) at $4.32 per share (Derivative)
  Date: 2025-12-08 | Code: M | Expires: 2026-07-26 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F5

Footnotes:

• F1: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan dated May 7th, 2025.
• F2: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.13 to $19.85, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.
• F3: Includes 10,307 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock.
• F4: Shares held by The Jeffrey W. Dunn Living Trust Dated May 17, 2012.
• F5: The shares subject to the option vest in equal monthly installments over four years commencing on the vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.